XASE
BESS
Market cap6mUSD
Jun 24, Last price
4.50USD
1D
-9.64%
1Q
79.28%
Jan 2017
2,150.00%
Name
Bitech Technologies Corp
Chart & Performance
P/E
165.58
P/S
12.95
EPS
0.03
Div Yield, %
—
Shrs. gr., 5y
-92.16%
Rev. gr., 5y
152.39%
Revenues
3m
Net income
210k
P
CFO
394k
+105.80%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Black Titan Corp. was established with the specific aim of orchestrating a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. Moving forward, the company intends to actively seek out and identify promising commercial prospects. Its inception date was July 11, 2024, and its principal operations are based in Petaling Jaya, Malaysia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑07 | 2024‑12 | 2024‑07 | 2023‑12 | 2023‑07 | 2022‑12 | 2022‑07 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||